🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pathological Complete Remission

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer NCT07635342Phase 21 site📍 Shijiazhuang Hebei Medical University Fourth Hospital · Tests: Pyrotinib Maleate, Trastuzumab (H, 8mg/kg, pegylated liposomal doxorubicin hydrochloride, Cyclophosphamide, Paclitaxel … I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer NCT01042379Phase 242 sites📍 Birmingham📍 Scottsdale📍 Tucson QuantumLeap Healthcare Collaborative · Tests: Standard Therapy, AMG 386 with or without Trastuzumab, AMG 479 (Ganitumab) plus Metformin, MK-2206 with or without Tras… Predicting Gastric Cancer Response to Chemo With Multimodal AI Model NCT06451393n/a1 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Neoadjuvant chemotherapy with radical tumor resection surgery Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer NCT06606730Phase 32 sites📍 Brussels📍 Villejuif UNICANCER · Tests: Pembrolizumab, Deescalation Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer NCT04743102NA1 site📍 Beijing Beijing Chao Yang Hospital · Tests: multi-points and full-thickness Biopsy, traditional cCR UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia NCT06245746Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo) Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer NCT07593976Phase 21 site📍 Rouen Centre Henri Becquerel · Tests: [68Ga]Ga-NOTA-anti-HER2-sdAb Positron Emission Tomography Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC) NCT07401199n/a9 sites📍 Fuyang📍 Cangzhou📍 Hengshui Qun Zhao · Tests: Standard of Care PD-1 Inhibitors, Multimodal AI Assessment Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer NCT07646301Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Iparomlimab and Tuvonralimab (QL1706), Paclitaxel, Cisplatin, Carboplatin Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer NCT07289282n/a1 site📍 Istanbul Atlas University ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab NCT06876714Phase 3702 sites📍 Phoenix📍 Phoenix📍 Fort Smith Alliance for Clinical Trials in Oncology · Tests: Trastuzumab (Herceptin), Pertuzumab, Echocardiography, Multigated Acquisition Scan, Mammography Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer NCT02306096n/a10 sites📍 Borås📍 Halmstad📍 Helsingborg Lund University Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB) NCT04293796NA1 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology · Tests: Vacuum-assisted biopsy THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy NCT04815694NA1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy NCT05866458n/a27 sites📍 Cudgen📍 Liverpool📍 North Sydney Ontario Clinical Oncology Group (OCOG) Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy NCT07088354n/a1 site📍 Wuhan Tongji Hospital · Tests: The high-throughput extraction of large amounts of quantitative image features from medical images Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients NCT07007052Phase 234 sites📍 Amiens📍 Angers📍 Argenteuil French Innovative Leukemia Organisation · Tests: Venetoclax, Tagraxofusp Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC NCT06811844Phase 23 sites📍 Xiamen📍 Zhangzhou📍 Haikou The First Affiliated Hospital of Xiamen University · Tests: Two-cycle induction chemotherapy + immunotherapy, Three-cycle induction chemotherapy + immunotherapy The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR NCT05854823NA1 site📍 Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University · Tests: dose-reduced radiotherapy Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer NCT06802757Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Posaconazole, Nab-paclitaxel, Carboplatin, Anthracycline, Cyclophosphamide Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma NCT07430579NA1 site📍 Jinan The Second Hospital of Shandong University · Tests: adebrelimab combined with chemotherapy Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC NCT05918328Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: Albumin paclitaxel+trastuzumab+pyrrolitinib, Docetaxel+Carboplatin+trastuzumab+Parstuzumab Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC NCT06939127Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Neoadjuvant Cryoablation Combined with Tislelizumab and Chemotherapy, Surgery, Adjuvant tislelizumab Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer NCT07166185n/a1 site📍 Blida Blida 1 University Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors NCT07586826Phase 21 site📍 Beijing Peking University People's Hospital · Tests: Romiplostim N01, All-trans retinoic acid Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery NCT06281210NA2 sites📍 Candiolo📍 Milan European Institute of Oncology · Tests: Omission of surgical treatment Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer NCT07353723Phase 21 site📍 Shanxi Tang-Du Hospital · Tests: Nimotuzumab, Toripalimab, Nab-paclitaxel, carboplatin Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients NCT04314219Phase 31 site📍 Riyadh King Faisal Specialist Hospital & Research Center · Tests: Cyclophosphamide 50mg, Methotrexate A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer NCT07899892Phase 18 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: 68Ga-FAPI-PET/MRI Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial NCT07407920Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Hormone Therapy, Pembrolizumab, Pertuzumab, Trastuzumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy